Enrique Dilone

Enrique Dilone

Chief Tech/Sci/R&D Officer at IMMUNITYBIO, INC.
59 year
Health Technology
Consumer Services
Commercial Services

Profile

Enrique Dilone is currently Director at La Casa de Don Pedro, Inc. and Chief Technology Officer at ImmunityBio, Inc. since 2023.
Formerly, Dr. Dilone was Executive Director-Quality & Analytics at NovaDel Pharma, Inc. from 2007 to 2009, Director-Analytical Operations at Oldtech, Inc. from 2002 to 2006, Senior Vice President-Technical Operations at Amicus Therapeutics, Inc. from 2009 to 2019, and Chief Technology Officer at Prothelia,.
Inc. Education includes undergraduate studies at New York University and graduate and doctorate degrees from Seton Hall University.

Enrique Dilone active positions

CompaniesPositionStart
IMMUNITYBIO, INC. Chief Tech/Sci/R&D Officer 2023-08-13
Director/Board Member -

Former positions of Enrique Dilone

CompaniesPositionEnd
AMICUS THERAPEUTICS, INC. Corporate Officer/Principal 2019-09-30
NOVADEL PHARMA INC Corporate Officer/Principal 2009-07-31
Corporate Officer/Principal 2006-11-30
Chief Tech/Sci/R&D Officer -
See the detail of Enrique Dilone's experience

Training of Enrique Dilone

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Enrique Dilone